KARD: Kardigan, Inc.
Performance
KARD -31.00%
Watchlist
Select an item
Summary
KARD at a glance
KARD returned -31.00% since Jun 18, 2026. Its worst drop since then was -51.24%, smaller than 22% of stocks on Redstone, and its Sharpe ratio of -0.95 beats 5% of stocks on Redstone. It hasn't paid a dividend since it listed.
Current Drawdown
-41.39%
Rolling Volatility
86.75%
Actions
Metrics
Risk Indicators*
Alpha-70.11%
Beta1.77x
Sharpe-0.95
Sortino-1.26
Omega0.85
Calmar-0.60
Martin-2.26
Profile
About KARD
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.4B
- Listed
- Jun 2026
- Headquarters
- South San Francisco, CA
- Website
- kardigan.bio
Comparisons